SEC Form 4 · accession 0001437749-17-011209
Oxford Immunotec Global PLC · OXFD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elizabeth M Keiley
Officer — Senior VP & General Counsel
Period of report
Jun 9, 2017
Accepted (ET)
Jun 13, 2017 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001586049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jun 9, 2017 | F | 1,136 | $14.63 | D | 29,478 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld to pay withholding taxes upon vesting of restricted share units originally granted on June 9, 2015. The number of shares withheld was determined based on the closing price on the date of vesting, June 9, 2017.